Press Release - A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024.

The newly prequalified vaccine, TAK-003 is developed by a multinational pharmaceutical company, Takeda as the second dengue ...

The World Health Organisation (WHO) prequalified a new dengue vaccine TAK-003 on May 10. TAK-003, developed by Takeda, is ...

The World Health Organization (WHO) said it had prequalified the second dengue vaccine, TAK-003 as a new weapon in the fight ...

The prequalification of TAK-003 is an important step in the expansion of global access to dengue vaccines, as it is now eligible for procurement by UN agencies including UNICEF. Photo: AFP A new ...

Dengue is a vector-borne disease transmitted by the bite of an infected mosquito. (Image Credits: Pixabay) The World Health Organization (WHO) on Wednesday announced that it has prequalified new ...

TAK-003 is the second dengue vaccine to be prequalified by WHO Geneva: The World Health Organization (WHO) said on Wednesday that it had prequalified Takeda Pharmaceuticals' dengue vaccine.

(MENAFN- Caribbean News Global) GENEVA, Switaerland – A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue ...

The World Health Organization (WHO) has prequalified a new dengue vaccine known as TAK-003. Developed by Takeda, this live-attenuated vaccine, which incorporates weakened forms of the four dengue ...

The World Health Organisation (WHO) this week pre-qualified a new vaccine for a mosquito-borne disease called –Dengue, which is mostly reported in the coastal part of Kenya. This is the first ever ...